StartUp Health February 4, 2025
A member of the StartUp Health Community, Grey Matter Neurosciences will use the funds to develop an ultrasound headset in clinical trials for people with Alzheimer’s Disease.
Grey Matter Neurosciences, a Toronto, ON, Canada-based neurotechnology company in the StartUp Health Alzheimer’s Moonshot Community, raised $14M, which will be used to develop an ultrasound headset for individuals with Alzheimer’s disease and test that device in clinical trials. The seed round of financing was led by the Wittington Innovation Fund, with participation from Toronto Innovation Acceleration Partners, Ontario Brain Institute, and Ontario’s Life Sciences Innovation Fund. source>
Other reported global health innovation funding this week included:
RadAI, a San Francisco, CA-based company that develops generative AI solutions for radiology, raised $60M led...
Today's Sponsors
Today's Sponsor